Stadion Money Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,207
Closed -$786K 50
2021
Q1
$786K Hold
4,207
0.04% 44
2020
Q4
$710K Hold
4,207
0.03% 51
2020
Q3
$623K Hold
4,207
0.02% 59
2020
Q2
$691K Hold
4,207
0.03% 51
2020
Q1
$584K Sell
4,207
-440
-9% -$60.5K 0.03% 41
2019
Q4
$611K Sell
4,647
-1,781
-28% -$206K 0.02% 70
2019
Q3
$719K Sell
6,428
-1,174
-15% -$131K 0.03% 77
2019
Q2
$842K Sell
7,602
-183
-2% -$21.6K 0.03% 80
2019
Q1
$1.01M Sell
7,785
-2,833
-27% -$344K 0.04% 64
2018
Q4
$1.23M Sell
10,618
-1,864
-15% -$208K 0.05% 53
2018
Q3
$1.34M Sell
12,482
-4,638
-27% -$464K 0.05% 48
2018
Q2
$1.46M Sell
17,120
-3,106
-15% -$255K 0.05% 57
2018
Q1
$1.56M Sell
20,226
-1,039
-5% -$83.6K 0.05% 71
2017
Q4
$1.8M Sell
21,265
-1,333
-6% -$113K 0.06% 67
2017
Q3
$1.93M Buy
22,598
+686
+3% +$56.3K 0.06% 65
2017
Q2
$1.8M Sell
21,912
-23,195
-51% -$1.89M 0.06% 76
2017
Q1
$3.79M Hold
45,107
0.12% 56
2016
Q4
$3.32M Buy
45,107
+7,154
+19% +$533K 0.1% 50
2016
Q3
$3.05M Buy
37,953
+1,475
+4% +$118K 0.09% 50
2016
Q2
$2.87M Buy
36,478
+200
+0.6% +$15.1K 0.1% 43
2016
Q1
$2.61M Buy
36,278
+8,057
+29% +$610K 0.08% 60
2015
Q4
$2.38M Buy
28,221
+1,068
+4% +$88.6K 0.09% 52
2015
Q3
$2.27M Sell
27,153
-18,875
-41% -$1.59M 0.13% 33
2015
Q2
$3.84M Sell
46,028
-10,542
-19% -$803K 0.19% 32
2015
Q1
$4.11M Buy
56,570
+5,117
+10% +$364K 0.13% 47
2014
Q4
$3.55M Buy
51,453
+2,871
+6% +$194K 0.08% 55
2014
Q3
$3.15M Buy
+48,582
New +$3.08M 0.13% 49

Other funds holding LLY

Stadion Money Management's LLY Position: Q2 2021 in Review

Stadion Money Management sold out of Eli Lilly (LLY) in Q2 2021, closing a stake of 4,207 shares — an estimated $786K sold.

Stadion Money Management first reported a position in LLY in Q3 2014 and held it in 27 quarters. The position peaked at $4.11M in Q1 2015. 2,021 funds tracked by Wall St. Rank hold LLY as of Q2 2021.

  • Stadion Money Management reported no remaining Eli Lilly position as of Q2 2021 after selling out during the quarter.
  • Stadion Money Management sold 4,207 Eli Lilly shares in Q2 2021, an estimated $786K.
  • Stadion Money Management first reported a position in Eli Lilly in Q3 2014 and held it in 27 quarters.
  • Stadion Money Management's Eli Lilly position peaked at $4.11M in Q1 2015.
  • 2,021 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2021.

Based on Stadion Money Management's 13F filing for Q2 2021, filed 16 Aug 2021.